Hypofractionated adjuvant whole breast radiotherapy: Progress and prospects

Acta Oncologica

Volumn 49, Issue 8, 2010, Pages 1288-1292

  Yarnold, John ^a   Haviland, Joanne ^a  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

Breast cancer; Clinical trials; Hypofractionation; Local tumour control; Normal tissues; Radiotherapy

Indexed keywords

ARTICLE; BREAST CANCER; CANCER CONTROL; CANCER RADIOTHERAPY; CANCER SURGERY; CLINICAL ASSESSMENT; EXTERNAL BEAM RADIOTHERAPY; HUMAN; PARTIAL MASTECTOMY; PRIORITY JOURNAL; RADIATION DOSE; RADIATION DOSE DISTRIBUTION; RADIATION DOSE FRACTIONATION;

ADULT; AGED; BREAST NEOPLASMS; DOSE FRACTIONATION; FEMALE; GREAT BRITAIN; HUMANS; MASTECTOMY, SEGMENTAL; MIDDLE AGED; RADIOTHERAPY, ADJUVANT; TREATMENT OUTCOME;

EID: 77958183224     PISSN: 0284186X     EISSN: 1651226X     Source Type: Journal    
DOI: 10.3109/0284186X.2010.509334     Document Type: Article

References (24)

1. Williams MV, Denekamp J, Fowler JF. A review of alpha/beta ratios for experimental tumors: implications for clinical studies of altered fractionation. Int J Radiat Oncol Biol Phys. 1985 Jan; 11 (1):87-96.
2. Thames HD, Bentzen SM, Turesson I, Overgaard M, van den Bogaert W. Fractionation parameters for human tissues and tumors. Int J Radiat Biol. 1989 Nov; 56 (5):701-10.
3. Douglas BG. Superfractionation: its rationale and anticipated benefits. Int J Radiat Oncol Biol Phys. 1982 Jul; 8 (7):1143-53.
4. Miles EF, Lee WR. Hypofractionation for prostate cancer: a critical review. Semin Radiat Oncol. 2008 Jan; 18 (1):41-7.
5. Withers HR, Thames HD, Jr., Peters LJ. A new isoeffect curve for change in dose per fraction. Radiother Oncol. 1983 Nov; 1 (2):187-91.
6. Fowler JF. The linear-quadratic formula and progress in fractionated radiotherapy. Br J Radiol. 1989 Aug; 62 (740):679-94.
7. Bates TD. The 10-year results of a prospective trial of postoperative radiotherapy delivered in 3 fractions per week versus 2 fractions per week in breast carcinoma. Br J Radiol. 1988 Jul; 61 (727):625-30.
8. Overgaard M, Bentzen SM, Christensen JJ, Madsen EH. The value of the NSD formula in equation of acute and late radiation complications in normal tissue following 2 and 5 fractions per week in breast cancer patients treated with postmastectomy irradiation. Radiother Oncol. 1987 May; 9 (1):1-11.
9. Whelan T, MacKenzie R, Julian J, Levine M, Shelley W, Grimard L, et al. Randomized trial of breast irradiation schedules after lumpectomy for women with lymph nodenegative breast cancer. J Natl Cancer Inst. 2002 Aug. 7; 94 (15):1143-50.
10. Yarnold J, Ashton A, Bliss J, Homewood J, Harper C, Hanson J, et al. Fractionation sensitivity and dose response of late adverse effects in the breast after radiotherapy for early breast cancer: long-term results of a randomised trial. Radiother Oncol. 2005 Apr; 75 (1):9-17.
11. Owen JR, Ashton A, Bliss JM, Homewood J, Harper C, Hanson J, et al. Effect of radiotherapy fraction size on tumour control in patients with early-stage breast cancer after local tumour excision: long-term results of a randomised trial. Lancet Oncol. 2006 Jun; 7 (6):467-71.
12. Bentzen SM, Agrawal RK, Aird EG, Barrett JM, Barrett-Lee PJ, Bliss JM, et al. The UK Standardisation of Breast Radiotherapy (START) Trial A of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial. Lancet Oncol. 2008 Apr; 9 (4):331-41.
13. Bentzen SM, Agrawal RK, Aird EG, Barrett JM, Barrett-Lee PJ, Bliss JM, et al. The UK Standardisation of Breast Radiotherapy (START) Trial B of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial. Lancet. 2008 Mar. 29; 371 (9618):1098-107.
14. James ML, Lehman M, Hider PN, Jeffery M, Francis DP, JHickey BE. Fraction size for radiation treatment for breast conservation in early breast cancer. Cochrane Database of Systematic Reviews. 2008 (3).
15. Whelan TJ, Pignol JP, Levine MN, Julian JA, Mackenzie R, Parpia S, et al. Long-Term Results of Hypofractionated Radiation Therapy for Breast Cancer. N Engl J Med. 2010 Feb. 11; 362 (6):513-20.
16. Bartelink H, Arriagada R. Hypofractionation in radiotherapy for breast cancer. Lancet. 2008 Mar. 29; 371 (9618):1050-2.
17. Bartelink H, Horiot JC, Poortmans PM, Struikmans H, Van den Bogaert W, Fourquet A, et al. Impact of a higher radiation dose on local control and survival in breastconserving therapy of early breast cancer: 10-year results of the randomized boost versus no boost EORTC 22881-10882 trial. J Clin Oncol. 2007 Aug. 1; 25 (22):3259-65.
18. Gagliardi G, Constine LS, Moiseenko V, Correa C, Pierce LJ, Allen AM, et al. Radiation dose-volume effects in the heart. Int J Radiat Oncol Biol Phys. 2010 Mar. 1; 76 (3 Suppl): S77-85.
19. Mannino M, Yarnold JR. Local relapse rates are falling after breast conserving surgery and systemic therapy for early breast cancer: Can radiotherapy ever be safely withheld? Radiother Oncol. 2009 Jan; 90 (1):14-22.
20. Borger J, Kemperman H, Hart A, Peterse H, van Dongen J, Bartelink H. Risk factors in breast-conservation therapy. J Clin Oncol. 1994 Apr; 12 (4):653-60.
21. Vrieling C, Collette L, Fourquet A, Hoogenraad WJ, Horiot JH, Jager JJ, et al. The influence of patient, tumor and treatment factors on the cosmetic results after breastconserving therapy in the EORTC 'boost vs. no boost' trial. EORTC Radiotherapy and Breast Cancer Cooperative Groups. Radiother Oncol. 2000 Jun; 55 (3):219-32.
22. Courdi A, Ortholan C, Hannoun-Levi JM, Ferrero JM, Largillier R, Balu-Maestro C, et al. Long-term results of hypofractionated radiotherapy and hormonal therapy without surgery for breast cancer in elderly patients. Radiother Oncol. 2006 May; 79 (2):156-61.
23. Kirova YM, Campana F, Savignoni A, Laki F, Muresan M, Dendale R, et al. Breast-conserving treatment in the elderly: long-term results of adjuvant hypofractionated and normofractionated radiotherapy. Int J Radiat Oncol Biol Phys. 2009 Sep. 1; 75 (1):76-81.
24. Brunt AM, Sydenham M, Bliss J, Coles CE, Gothard L, Harnett A, et al. A 5-fraction regimen of adjuvant radiotherapy for women with early breast cancer: first analysis of the randomised UK FAST trial (ISRCTN62488883, CRUKE/04/015). EJC Supplements Presidential sessions late breaking and best of ECCO 15-ESMO 34 Abstracts. 2009 20-24 September 2009;7(3):2.